RxDoctor Payments Data

Danny Shaban, MD

Obstetrics & Gynecology · Mechanicsville, VANPI 1992707517

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,824 of the $8,040 with a category attached, or 84.9%. It is spread thinly across 48 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,131 and has fallen 50.4% since, to $1,057 in 2025. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,040in general payments, 2019–2025

Across 414 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Medical Device Business Services, Inc.$1K
  • Amgen$576
  • Mayne Pharma Commercial LLC$538
  • Myovant Sciences Inc.$505
  • Organon$445
  • plus $3K from 42 others

What the payments were for

  • Travel & lodging$1,16014%
  • Food & beverage$6,82485%
  • Education$571%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,040 in reported general payments places this provider in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.

See all obstetrics & gynecology providers in Virginia

Medicare billing

Part B allowed, 2024
$14,881
Medicare patients
77
Services billed
203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide24$27,379
OzempicSemaglutide13$16,201
PremproEstrogen,con/M-Progest Acet12$2,893
Estradiol45$1,786
Raloxifene Hcl15$454
Spironolactone29$268
Fluconazole26$99
Acyclovir12$97
Blisovi FeNorethindrone-E.Estradiol-Iron12$84
Levothyroxine Sodium11$35

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$76$27,37924 claims
Novo NordiskOzempic$313$16,20113 claims
PfizerPrempro$140$2,89312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.

Other obstetrics & gynecology in Mechanicsville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →